Those notificantions will cease in about 2 weeks when one more set of shares are due to be released. I agree with you that the way the stock was placed into so many different escrow packages was stupid and it is the first time I have ever seen so many (i knew this though as it was listed in the orginal notcie when added to the ASX)
I have been picking up in the high 7's to 10c range. They have great sales growth and SOLID margins so as they grow so will EBITDA. Too many other product based business (like infant formula companies and listed food and bevearge companies) marging are way too fine and therefore need massive revenue growth to even get into profit.
think both BIO and HPC have excellent margins and will keeep buying.
- Forums
- ASX - By Stock
- BIO
- Ann: Application for quotation of securities - BIO
Ann: Application for quotation of securities - BIO, page-17
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add BIO (ASX) to my watchlist
(20min delay)
|
|||||
Last
68.0¢ |
Change
0.015(2.26%) |
Mkt cap ! $149.0M |
Open | High | Low | Value | Volume |
66.5¢ | 69.0¢ | 66.0¢ | $173.2K | 255.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 46226 | 68.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
69.0¢ | 83602 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 44195 | 0.680 |
1 | 1000 | 0.670 |
8 | 41745 | 0.660 |
1 | 16550 | 0.655 |
5 | 27476 | 0.650 |
Price($) | Vol. | No. |
---|---|---|
0.690 | 48000 | 2 |
0.700 | 11170 | 2 |
0.705 | 5839 | 1 |
0.720 | 44230 | 3 |
0.735 | 18000 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
BIO (ASX) Chart |